News
WALTHAM, Mass. - Repligen Corporation (NASDAQ:RGEN), a bioprocessing company with a market capitalization of $6.9 billion and annual revenue of $650 million, has formed a strategic partnership with Au ...
Headlines,Dow slips as Jerome Powell offers no hints about a September rate change,Treasury yields hit session highs amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback